Empaveli
EU gives narrower label to Apellis, Sobi’s PNH drug
Phil Taylor
Alexion, Apellis Pharma, Aspaveli, AstraZeneca, Empaveli, paroxysmal nocturnal haemoglobinuria, pegcetacoplan, rare disease, regulatory approval, SOBI, Soliris, Ultomiris
0 Comment
X
EU gives narrower label to Apellis, Sobi’s PNH drug
https://pharmaphorum.com/news/eu-gives-narrower-label-to-apellis-sobis-pnh-drug/
Apellis reports mixed data with eye drug, but plans to file anyway
Phil Taylor
Apellis Pharma, blindness, complement therapeutics, Empaveli, geographic atrophy, ophthalmology
0 Comment
X
Apellis reports mixed data with eye drug, but plans to file anyway
https://pharmaphorum.com/news/apellis-reports-mixed-data-with-eye-drug-but-plans-to-file-anyway/
Apellis set to take on Alexion as FDA clears PNH drug Empaveli
Phil Taylor
Alexion, Apellis Pharma, AstraZeneca, Empaveli, rare disease, Soliris, Ultomiris
0 Comment
X
Apellis set to take on Alexion as FDA clears PNH drug Empaveli
https://pharmaphorum.com/news/apellis-set-to-take-on-alexion-as-fda-clears-pnh-drug-empaveli/